Deep Flaws in FDA Oversight of Medical Devices, and Patient Harm, Exposed in Lawsuits and Records
(By Fred Schulte and Holly K. Hacker for KFF Health News) Living with diabetes, Carlton “PeeWee” Gautney Jr. relied on
Read More
FDA
Patients Facing Death Are Opting for a Lifesaving Heart Device — But at What Risk?
(By Daniel Chang and Holly K. Hacker for KFF Health News) Too old and too sick for a heart transplant,
Read MoreColorado Blames Biden Team and Drugmakers for Delaying Canadian Imports
(By Phil Galewitz for KFF Health News) Colorado officials say their plan to import cheaper medicines from Canada has been
Read MorePatients Expected Profemur Artificial Hips to Last. Then They Snapped in Half.
(By Brett Kelman and Anna Werner, CBS News and KFF Health News) Bradley Little, a physical education teacher in Arizona,
Read MoreManufacturers need to be more open about a dangerous Alzheimer’s drug side effect
(By Madhav Thambisetty for STAT) Since the FDA’s approval of lecanemab (marketed as Leqembi) and Medicare’s recent decision to cover
Read MoreNew Alzheimer’s Drug Raises Hopes — Along With Questions
(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read MoreNew ALS medication offers hope
(Source – news.va.gov) A Marine Corps Veteran got an infusion of hope this week when he became the second patient
Read MoreKFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs
(By Alex Montero, Grace Sparks, Ashley Kirzinger, Isabelle Valdes, and Liz Hamel for Kaiser Family Foundation Published: Aug 04, 2023)
Read MoreThe Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read MoreAn experimental Alzheimer’s drug outperforms one just approved by the FDA
(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer’s may soon have a new option to stave
Read More